Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in sickle cell disease: A phase 2, open‐label study. Issue 7 (16th April 2022)

• Record Type: Journal Article
• Authors: van Dijk, Myrthe J.; Rab, Minke A. E.; van Oirschot, Brigitte A.; Bos, Jennifer; Derichs, Cleo; Rijneveld, Anita W.; Cnossen, Marjon H.; Nur, Erfan; Biemond, Bart J.; Bartels, Marije; Jans, Judith J. M.; van Solinge, Wouter W.; Schutgens, Roger E. G.; van Wijk, Richard; van Beers, Eduard J.
• Is Part Of: American journal of hematology. Volume 97:Issue 7(2022)
• Page Start: E226
• Page End: E229
• Publication Date: 2022-04-16
• Subjects: Hematology -- Periodicals; 616.15
• DOI: 10.1002/ajh.26554
• Languages: English
• ISSNs: 0361-8609

Abstract

Abstract :